Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
Crossref DOI link: https://doi.org/10.1186/s13045-016-0296-8
Published Online: 2016-08-05
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gu, Fei-fei
Zhang, Yong
Liu, Yang-yang
Hong, Xiao-hua
Liang, Jin-yan
Tong, Fan
Yang, Jing-song
Liu, Li
Funding for this research was provided by:
National Natural Science Foundation of China (81372260)
